Empagliflozin (Jardiance)
The objective of this review was to perform a systematic review of the beneficial and harmful effects of empagliflozin for the treatment of adults with type 2 diabetes who have experienced inadequate glycemic control on combination therapy with metformin and a sulfonylurea
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2015, October 2015
|
| Series: | CADTH common drug review clinical review report
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this review was to perform a systematic review of the beneficial and harmful effects of empagliflozin for the treatment of adults with type 2 diabetes who have experienced inadequate glycemic control on combination therapy with metformin and a sulfonylurea |
|---|---|
| Item Description: | "Manufacturer, Boehringer Ingelheim." |
| Physical Description: | 1 PDF file (ix, 58 pages) illustrations |